People with age-related macular degeneration (AMD) often do not know they have the disease during its early stages. They may dismiss early warning signs, like trouble seeing at night, as part of the normal aging process. Ignoring these symptoms only delays diagnosis, which can lead to more vision loss.
As an AMD Center of Excellence® we offer a new test that helps us diagnose AMD at a very early stage and monitor disease progression. If you are experiencing problems seeing at night, or it is becoming increasing difficult to read in dim light, talk to us about scheduling an AdaptDx® test.
The AdaptDx [adapt-dee-ex] aids in the detection and management of AMD. It measures the time it takes for your vision to adjust to the dark. This is called dark adaptation. The simple test takes less than 10 minutes. You’ll look into the device in a darkened room and press a button every time you see a flashing light. Nothing will touch your eye. If the AdaptDx test indicates signs of early AMD, you and your doctor have valuable time to develop a plan to delay disease progression.
“RI” stands for Rod Intercept™,the time it takes for the eye to adjust from bright light to darkness When you take the AdaptDx test, the device calculates your RI number and provides your doctor with critical information to help determine your AMD status.
We may be able to bill the test to your insurance provider if there is a medical diagnosis related to AMD or you are experiencing trouble seeing, If not, the AdaptDx test may require a modest out-of-pocket expense.
Age-related macular degeneration or AMD is the leading cause of adult blindness in developed countries and affects nearly 1 in 8 adults over the age of 60. AMD is a chronic, progressive disease that attacks the macula, a part of the retina that allows us to see objects located straight ahead of us. The macula is responsible for your central vision, which allows you to do things like recognize faces, read, and watch TV
Identifying AMD early allows an eye doctor to take action before significant vision loss has occurred. Putting a treatment plan in place at the earliest possible time will preserve as much vision as possible over a longer duration. Drs. Dobbins and Letourneau Eyecare is among the first in the area to offer patients a test to detect AMD in its earliest stages before irreversible damage to the retina has occurred. The diagnostic aid, AdaptDx®, offers a simple, noninvasive test measuring dark adaptation, the earliest symptom, and biomarker for AMD. We can indicate the presence of the disease at least three years before it becomes clinically evident.
The AdaptDx® test lasts less than 10 minutes and can easily fit into a comprehensive eye examination. Prevent blindness with this disease, get tested today!